Background: Medicinal plants are rich sources of bioactive compounds that contribute to their therapeutic applications. This study investigates the phytochemical composition and pharmacological activities of [specific plant species] to validate its traditional medicinal uses.

Methods: Methanolic extracts of the plant were analyzed for total phenolic and flavonoid contents using spectrophotometric methods. High-performance liquid chromatography (HPLC) identified key bioactive compounds. Antioxidant, antimicrobial, and anti-inflammatory activities were assessed using DPPH, FRAP, disc diffusion, MIC, and enzyme inhibition assays.
Statistical Analysis: All experiments were performed in triplicates, and results are presented as mean ± standard deviation.
Data were analyzed using one-way ANOVA followed by Tukey’s post hoc test to determine significant differences among groups (p < 0.05).

Statistical analyses were conducted using GraphPad Prism (version 9.0).

Results: The extract exhibited high phenolic (85.6 ± 2.1 mg GAE/g) and flavonoid (62.3 ± 1.8 mg QE/g) content, with rutin (15.2 ± 0.4 mg/g) and quercetin (9.8 ± 0.3 mg/g) as dominant compounds. Antioxidant activity showed a DPPH IC50 of 32.5 ± 1.2 µg/mL and a FRAP value of 430.2 ± 12.6 µmol Fe (II)/g. Antimicrobial assays revealed inhibition zones of 16.4 ± 0.5 mm (E. coli) and 14.7 ± 0.3 mm (S. aureus), with MIC values of 62.5 and 125 µg/mL, respectively. Anti-inflammatory assays demonstrated an IC50 of 41.2 ± 1.5 µg/mL for protein denaturation and 65.3 ± 2.0% COX-2 inhibition.